The only international event dedicated to discussing regulatory, ethical and operational aspects of running clinical trials in Russia
30 November - 1 December 2021
Moscow, Russia, Intercontinental Hotel
Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation
Eurasian Economic Commission
Director
“Genome” Patient Support Centre
Medical devices department lector
RMANPO
Head of Medical Projects Group
Takeda
Director of Clinical Research & Medical Affairs
AIPM Russia
Head of Clinical Operations
Novartis Pharma
Head of department of clinical trials
Sechenov University
Head of the Department for Pre-Clinical and Clinical Trials
National Medical Research Centre of Oncology Named after N.N.Petrov
Head
Republican Clinical and Pharmacological Laboratory, Republican Unitary Enterprise "Center for Examinations and Tests in Health Service"
KEY TOPICS & FEATURES IN 2020:
o The current status of the clinical trials market: what are the latest trends in Russia and globally?
o Clinical trials during the Covid-19 pandemic: practical experiences, challenges and solutions found
o Clinical trials in the Eurasian Union - registration practices and common rules in action
o Acceleration of digitalisation in clinical trials: AI, remote monitoring, electronic registers, access to data and data safety
o RWE - globally and in Russia: RWE as a key tool for the federal project “Digital technologies”
o Live Interviews with sponsors and research & investigators centres
Insights from 40+ experts: regulators, representatives of international and Russian pharmaceutical producers, CROs and investigators
2-day information-rich programme that includes insightful presentations from leading sector players, interactive debates and round tables
Unrivalled networking opportunities with 150+ attendees from such companies as AstraZeneca, Pfizer, Novartis, Bayer, Biocad, R-Pharm and many more
Unique opportunity for all the clinical trials sector players to meet and discuss the most burning issues.
The forum brings together representatives of all stakeholder groups involved in clinical trials – sponsors, CROs, regulators and investigators for a constructive dialogue aimed at improving all future processes.
Very good overview of a large number of clinical trial topics and the specifics of the Russian market.
Very interesting insight into the latest developments in the Russian market.
